BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1022@pharmaconomics
DTSTAMP:20260707T033906Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:KYTX PDUFA — miv-cel
DESCRIPTION:The FDA's approval decision on miv-cel for stiff person syndrome is due Jun 30\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1994702/000119312526009810/kytx-ex99_1.htm\n\nTrack it: https://pharmaconomics.com/e/1022
URL:https://pharmaconomics.com/e/1022
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:KYTX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR